Murtuza Rampurwala to Drug Administration Schedule
This is a "connection" page, showing publications Murtuza Rampurwala has written about Drug Administration Schedule.
Connection Strength
0.063
-
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel. Cancer Chemother Pharmacol. 2018 08; 82(2):211-219.
Score: 0.034
-
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer. Clin Cancer Res. 2016 06 01; 22(11):2659-67.
Score: 0.029